Interestingly, treatment of Y-79 cells, human retinoblastoma cells that endogenously express α3β2, with recombinant RS1 resulted in decreased expression of the pro-apoptotic BCL-2 associated X protein (BAX). This evidence concerns the gene RS1 and retinoblastoma.